DCL: Cuu Long Pharmaceutical Joint Stock Company - Summary | Jitta

Cuu Long Pharmaceutical Joint Stock Company

VNM:DCL

Price
₫37,300.00
Loss Chance
54.1%
2.36JITTA SCORE
617.36%Over Jitta Line
Jitta Ranking
540 / 622
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (22)
Recent Business Performance (29)
Financial Strength (65)
Return to Shareholders (2)
Competitive Advantage (40)
Jitta Signs
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 86.77% in the last quarter (yoy)
CapExVery High
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
2.36
617.36%
4.34
205.69%
3.94
171.55%
Pharmaceuticals
5.90
74.70%
4.60
133.75%
4.51
71.29%
COMPANY DESCRIPTION
Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antihistamine, musculoskeletal, dermatology, analgesics and antipyretics, antibiotics, analgesics and anti-inflammatories, respiratory, gastrointestinal, cardiovascular, vitamins and minerals, and nervous medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, pharmacies, and drugstores. The company was founded in 1976 and is headquartered in Vinh Long, Vietnam. Cuu Long Pharmaceutical Joint Stock Company operates as a subsidiary of F.I.T Group Joint Stock Company.